Reviva to participate in the h.c. wainwright 6th annual neuro perspectives hybrid conference

Cupertino, calif., june 05, 2025 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will present at the h.c. wainwright 6th annual neuro perspectives hybrid conference, taking place june 16-17, 2025.
RVPH Ratings Summary
RVPH Quant Ranking